LEO Pharma A/S: ifrs:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss

Value{"amount": 2250000000.0}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityLEO Pharma A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:52990077KVK7QCK2NG31:2024-12-31
Retrieved: 2026-08-23T23:26:08.487466+02:00
Raw response sha256: 607bee78798b47a37dd1ca8fc806eb61…
Cite as: FACTANKER, https://factanker.com/fact/feebb0f6-d6f7-4532-be49-ec3c6011c328

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies